+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of Yoku-kan-san on undifferentiated somatoform disorder with tinnitus

Effects of Yoku-kan-san on undifferentiated somatoform disorder with tinnitus

European Psychiatry 20(1): 74-75

Up to the present, there have been few strategies that are completely effective in treating undifferentiated somatoform disorder with tinnitus. We herein report that Yoku-kan-san (TJ-54), one of Japan's traditional herbal medicines, is an effective treatment for tinnitus in undifferentiated somatoform disorder complicated with headache and insomnia. TJ-54 has been also used as an effective treatment for insomnia and irritability in recent centuries and is considered to have some effects on the excitability of nerves. Further studies are needed to confirm the efficacies of Japanese herbal medicines.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012009186

Download citation: RISBibTeXText

PMID: 15642449

DOI: 10.1016/j.eurpsy.2004.09.034

Related references

Somatic symptom disorder and undifferentiated somatoform disorder, which is broader? Response to "Clinical value of DSM IV and DSM 5 criteria for diagnosing the most prevalent somatoform disorders in patients with medically unexplained physical symptoms (MUPS)". Journal of Psychosomatic Research 89: 114-115, 2016

Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry 54(4): 352-358, 1997

Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. Journal of Clinical Psychiatry 71(12): 1576-1581, 2010

Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. Journal of Clinical Psychiatry 73(5): E574-E579, 2012

Somatization disorder and undifferentiated somatoform disorder. Gabbard, G O [Author] Treatments of psychiatric disorders, Second edition, Vols 1 and 2 1717-1733, 1995

Undifferentiated somatoform disorder and biopsychosocial approach. Psiquis 24(4): 19-23, 2003

Serotonin-related gene pathways associated with undifferentiated somatoform disorder. Psychiatry Research 189(2): 246-250, 2011

Conceptual issues in undifferentiated somatoform disorder and chronic fatigue syndrome. Current Opinion in Psychiatry 19(6): 613-618, 2006

Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Research 202(3): 252-256, 2012

Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study. Current Therapeutic Research Clinical and Experimental 69(3): 221-231, 2008

Acoustic neuroma identified after electroconvulsive therapy in a patient with recurrent major depression and undifferentiated somatoform disorder. Journal of Ect 26(4): 330-331, 2010

Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial. Clinical Drug Investigation 28(4): 251-261, 2008

Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32(2): 437-444, 2008

The concept of comorbidity in somatoform disorder--a DSM-V alternative for the DSM-IV classification of somatoform disorder. Journal of Psychosomatic Research 68(1): 97-9; Author Reply 99-100, 2010

A comparison of tricyclic antidepressant response in patients with somatoform pain disorder somatoform pain disorder with major depression and major depressive disorder. Pain (Suppl. 5): S327, 1990